Back to rankings
Glyconutrients · est. 1993

Mannatech

Public (MTEX). Texas. Ambrotose line is the legacy.

Up 3 from #25
Median rep earns
They don't tell, but…

Earnings for reps in Mannatech are 100% production-based — reps are paid only on what they and their team sell. No salary, no hourly, no showing up for a paycheck.

Rank
#22
Momentum
rising

Last updated 2026-06-05

Current Rank
#22
Previous #25
Momentum
52
out of 100
30-Day Trend
+6%
90-Day Trend
-19%

Why Mannatech moved

Over the last 30 days, Mannatech gained an estimated+6%of momentum, driven by steady micro-cap while contending with stuck in pre-2010 narrative. That moved them up to rank #22.

🔥

Buzz check

What people are actually Googling about this company right now.

👂

Overheard about Mannatech

Leadership moves, momentum shifts, lawsuits, launches — what the scouts picked up.

Listening…

📰

In the news

Latest headlines, lawsuits, launches, and press.

In the News

Last 90 days · Google News
💬

Field pulse

What reps and former reps are saying on the ground.

Field Pulse

Agree with this ranking?

Be the first to weigh in.
💵

Earnings reality

What reps actually make — straight from the income disclosure.

Are they making money there?

No published earnings disclosure on file for Mannatech as of 2026-06-05.

Important caveat

To earn any income, someone must sell the product — bring in paying customers. This is not easy for the average person hoping they'll make money in the first week or two. As usual, it's the 90-10 rule. 10% of the people bring in 90% of the money because they sell, recruit and keep their customers. PS These numbers include everyone who signed up — even just to look.

Growth & risk signals

1 growth signal · 1 risk signal at a glance.

Growth signals

  • Steady micro-cap

Risk signals

  • Stuck in pre-2010 narrative
📈

Trend charts

Momentum and ranking over the last 12 weeks.

Momentum · 12 weeks

Daily signal blend.

+6%

Ranking · 12 weeks

Lower is better.

#22
🔗

Related companies

Neighbors in the rankings and head-to-head rivals.